Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

2022 ESC/ERS pulmonary hypertension guidelines incorporate changes and adaptations
focusing on clinical management https://bit. ly/3QtUvb4

Making a firm diagnosis of chronic heart failure with preserved ejection fraction (HFpEF)
remains a challenge. We recommend a new stepwise diagnostic process, the 'HFA–PEFF …

In patients with left ventricular heart failure (HF), the development of pulmonary hypertension
(PH) and right ventricular (RV) dysfunction are frequent and have important impact on …

Importance Heart failure with preserved ejection fraction (HFpEF) is highly prevalent, yet
there are no specific therapies, possibly due to phenotypic heterogeneity. The development …

Aims Pulmonary hypertension (PH) and pulmonary vascular disease (PVD) are common
and associated with adverse outcomes in heart failure with preserved ejection fraction …

Pulmonary hypertension remained an unexplained intractable disease with poor prognosis.
In the last 2 decades, however, the diagnosis and treatment methods for this disease …

Aims Little data are available regarding prognostic implications of invasive exercise testing
in heart failure with preserved ejection fraction (HFpEF). The present study aimed to …

The normal pulmonary circulation is a low-pressure, high-compliance system. Pulmonary
arterial compliance decreases in the presence of pulmonary hypertension because of …

Pulmonary hypertension (PH) is a progressive disease that arises from multiple etiologies
and ultimately leads to right heart failure as the predominant cause of morbidity and …